title: Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.
authors.forename: L A
authors.initials: LA
authors.lastname: Papp
authors.forename: J R
authors.initials: JR
authors.lastname: Weiss
authors.forename: H E
authors.initials: HE
authors.lastname: Greenberg
authors.forename: A
authors.initials: A
authors.lastname: Rifkin
authors.forename: S M
authors.initials: SM
authors.lastname: Scharf
authors.forename: J M
authors.initials: JM
authors.lastname: Gorman
authors.forename: D F
authors.initials: DF
authors.lastname: Klein
mesh_terms: D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000453:epidemiology; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000453:epidemiology*; D016584:Panic Disorder / Q000188:drug therapy / Q000453:epidemiology; D015995:Prevalence; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
chemical_list: D015057:1-Naphthylamine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline